 

Active ingredient: Bisoprolol Fumarate 

 

Form/Route: Tablets/Oral 

 

Recommended studies: 2 studies 

 

1. Type of study: Fasting 
Design: Single-dose, two-way crossover in-vivo 

Strength: 10 mg 

Subjects: Normal healthy males and females, general population. 

Additional Comments: 




______________________________________________________________________________ 

 

2. Type of study: Fed 
Design: Single-dose, two-way crossover in-vivo 

Strength: 10 mg 

Subjects: Normal healthy males and females, general population. 

Additional comments: 




______________________________________________________________________________ 

 

Analytes to measure: Bisoprolol in plasma 

 

Bioequivalence based on (90% CI): Bisoprolol 

 

Waiver request of in-vivo testing: 5 mg based on (i) acceptable bioequivalence 

studies on the 10 mg strength, (ii) proportionally similar across all strengths, and (iii) 

acceptable in vitro dissolution testing of all strengths. 

 

Dissolution test method and sampling times: 

 

Please conduct comparative dissolution testing on 12 dosage units of all strengths of the test and 
reference products using the following USP method. 

 


